Parathyroid hormone (PTH) is released from the parathyroid glands and regulates bone and mineral metabolism. It is a single-chain 84-amino acid polypeptide with a molecular weight of 9,425 Daltons. It is synthesized and secreted by the parathyroid glands, and rapidly cleared from plasma (half-life <5 min). PTH is metabolized to C-terminal fragments by the liver and kidneys, and cleared by the kidney, either as intact PTH or as C-terminal fragments [1] . Background : The objective of this study was to evaluate the role of proteases on the degradation of parathyroid hormone (PTH) in blood samples.
residues 36 and 37. Kupffer cells, but not hepatocytes, were found to be responsible for cleavage at these sites [2] .
PTH concentrations in serum specimens are reduced after incubating at room temperature for more than a few hours [3] [4] [5] , probably due to proteolytic cleavage by proteases.
Proteases generally have 5 groups (serine, cysteine, aspartic, metallo, and threonine). Some proteases of these groups, including metalloproteases, need metal ions as cofactors in the enzymatic reactions, and so these proteases are called metal ion-dependent proteases. For metalloproteases, they contain one or two metal ions (in most cases zinc but also cobalt, nickel or manganese) that are usually bounded by three amino acids in the catalytic nucleophile [6] . There are a number of proteases in blood, including serine proteases (thrombin, protein C, factor VII, IX, X, and XII, plasmin, tissue plasminogen activator, urokinase plasminogen activator), cysteine proteases (cathepsins), metalloproteases (gelatinase A, matrixins), aspartic proteases, and threonine proteases [6] [7] [8] . Blood also contains endogenous inhibitors of many of these proteases.
PTH is shown to be stable at room temperature for approximately 2 days in plasma containing ethylene diamine tetra-acetic acid (EDTA), at a clinically used concentrations in blood specimen [5, 9] . However, since the concentration of EDTA used in the blood collection is about 5,000 μ M, a concentration sufficient to remove almost all metal ions in blood samples, including zinc, calcium, and copper, it is impossible to distinguish whether the effect of EDTA is inhibition of proteolysis by metalloproteases or metal iondependent proteases [10, 11] .
To date, it remains unclear which class or classes of proteases are involved in degrading PTH in serum and plasma specimens. The objective of this study was to evaluate the role of proteases on the degradation of PTH in blood samples. 
MATERIALS AND METHODS

Blood collection and PTH measurement
Statistics
A Wilcoxon signed-rank test was used to compare initial PTH levels to those after 48 hr of storage and was also used to compare the PTH levels between different storage conditions. A P value <0.05 was considered statistically significant. Statistical analyses were performed using the SPSS program (Version 11.5, SPSS Inc., Chicago, IL, USA).
RESULTS
EDTA of 10 μ M did not prevent clot formation, nor did any of the other protease inhibitors, with the exception of leupeptin.
At zero time, PTH levels in all samples with the exception of leupeptin showed almost the same as each other. The mean concentration of PTH in samples with leupeptin was 20.1% higher than that in samples without protease inhibitors. This difference was considered to be caused by the effect of leupeptin on the measurement process of the PTH assay kit (Table 1, Fig. 1 
DISCUSSION
Consistent with previous reports, we found that PTH lev- 24.7% to 9.6% at 24 hr [12] .
E-64, a cysteine protease inhibitor, and EDTA, a metalloprotease inhibitor, were ineffective to protect PTH degradation. Our data are a contrast to previous reports on the effects of EDTA [5, 9, 12, 13 PTH remained stable in EDTA-plasma for 36 hr at 30℃ [5, 9] . These differences likely reflect due to differences in EDTA concentrations used. In the current study, EDTA was used at 10 μ M, a concentration recommended by the manufacturer to effectively inhibit metalloproteases. However, the previous studies used EDTA at concentrations of about 5,000 μ M to obtain plasma, that is higher enough to remove almost all metal ions in blood samples, including zinc, calcium, and copper [10, 11] . EDTA displays a high binding constant for zinc and a weak one for calcium and magnesium (about 1.5 times and 2 times, respectively) [11] . So, at the low concen- Leupeptin is also known to have inhibitory activity toward proteases involved in blood coagulation and fibrinolysis [14, 15] . In the present study, leupeptin of 100 μ M could prevent blood coagulation, but the protease inhibitor containing 1 μ M leupeptin could not prevent coagulation. This finding seemed to be due to the difference in concentration of leupeptin.
Although PTH level was more stable in serum specimen stored at 4℃ compared to serum specimen at room temperature, the mean PTH reductions after 12 hr, 24 hr, and 48 hr storage at 4℃ were 6.4%, 14.8%, and 20.1%, respectively. Therefore, although serum specimen is stored at 4℃, careful attention to the interpretation of PTH levels meaParathyroid Hormone Degradation by Protease Inhibitorssured after 12 hr of storage would be given. PTH is unstable in serum specimen even stored at 4℃. Thus, adding protease inhibitors to serum appears to be a good method to prevent the degradation of PTH for some days.
In conclusion, PTH degradation in blood specimen would be protease-dependent and various proteases, including especially serine proteases, would act together to degrade PTH in blood specimen. 
